[AGRANULOCYTOSIS AND MEDULLARY APLASIA DURING THERAPY WITH HYPOGLYCEMIC SULFONAMIDES. DEMONSTRATION OF AN ANTI-LEUKOCYTE ANTIBODY].
D000380:Agranulocytosis; D000486:Allergy and Immunology; D000740:Anemia; D000741:Anemia, Aplastic; D002271:Carbutamide; D003920:Diabetes Mellitus; D004342:Drug Hypersensitivity; D004358:Drug Therapy; D006967:Hypersensitivity; D007004:Hypoglycemic Agents; D007962:Leukocytes; D010827:Physiology; D013449:Sulfonamides; D014116:Toxicology
D007004:Hypoglycemic Agents; D013449:Sulfonamides; D002271:Carbutamide
AGRANULOCYTOSIS; ANEMIA, APLASTIC; CARBUTAMIDE; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; DRUG THERAPY; HYPERSENSITIVITY; IMMUNOLOGY; LEUKOCYTES; PHYSIOLOGY; TOXICOLOGIC REPORT
AGRANULOCYTOSE ET APLASIE M'EDULLAIRE AU COURS DE LA TH'ERAPEUTIQUE PAR LES SULFAMIDES HYPOGLYC'EMIANTS. MISE EN 'EVIDENCE D'UN ANTICORPS ANTI-LEUCOCYTAIRE.